Synthesis of Danuglipron: An Orally Available GLP-1R Agonist

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2022; 18(09): 1025
DOI: 10.1055/s-0041-1738304

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Ferdinand H. Lutter (Janssen Pharmaceutica)

danuglipron - Buchwald–Hartwig etherification - benzimidazoles - chemoselective saponification - antidiabetics - PF-06882961

Article published online:
18 August 2022

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany